Paul Rennie
Vorstandsvorsitzender bei PARADIGM BIOPHARMACEUTICALS LIMITED
Vermögen: 4 Mio $ am 30.04.2024
Profil
Paul John Rennie is the founder of Paradigm Biopharmaceuticals Ltd., which was founded in 2014.
He currently holds the position of Executive Chairman & Managing Director at the company.
In addition to his founding position, Mr. Rennie has held former positions at Neuroscientific Biopharmaceuticals Ltd.
as Non-Executive Chairman from 2021 to 2023, Stiefel Research Australia Pty Ltd.
as Director-Business Development, Merck KGaA as National Manager-Sales Marketing, Bonlac Foods Ltd.
as Manager-Business Development, Mesoblast Ltd.
as Executive Vice President-New Product Development, and Roche Diagnostics Australia Pty Ltd.
as Manager-Sales & Marketing.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.02.2024 | 20 678 805 ( 5,90% ) | 4 Mio $ | 30.04.2024 |
Aktive Positionen von Paul Rennie
| Unternehmen | Position | Beginn |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Vorstandsvorsitzender | 22.11.2022 |
Ehemalige bekannte Positionen von Paul Rennie
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Vorstandsvorsitzender | 11.09.2023 |
Stiefel Research Australia Pty Ltd.
 Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Corporate Officer/Principal | - |
| MERCK KGAA | Vertrieb & Marketing | - |
| Roche Diagnostics Australia Pty Ltd. | Vertrieb & Marketing | - |
| MESOBLAST LIMITED | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MESOBLAST LIMITED | Health Technology |
| PARADIGM BIOPHARMACEUTICALS LIMITED | Health Technology |
| MERCK KGAA | Health Technology |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Bonlac Foods Ltd.
 Bonlac Foods Ltd. Food DistributorsDistribution Services Bonlac Foods Ltd. manufactures dairy products and ingredients for domestic and international customers. The firm products include fresh & UTH milk, milk powders, cheese, spreads, fruit juice, sport drinks, and yoghurts. The company is located in Melbourne, Australia. | Distribution Services |
| Roche Diagnostics Australia Pty Ltd. | |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Health Technology |
